Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You old penny flipper you...
Caught in the round trip-up?
I see a new 52 week high coming soon!
Hold tight you won't be disappointed. Was looking to add at .185 but my broker can't let me trade for few days.
Up .04 off the days low 2 hours in...
A solid clip.out of .20...Wiped out a 300% gain yesterday doubling my position at 17.80....My lower buy order for today never filled...bye bye teens.
Good ! Sounds like most realistic talk .
very encouraging price action today!
What a difference a day can make! Let's rumble up to that .22 you were predicting for the EOD!
This is running on Fundamentals, trading on technicals is the the way to play this one.
$.35 very soon! New investors showing up every day!
What an Amazing Day Fellas! Told y'all about today going to be nice yesterday while so many were whining about the -17% at one point. Don't have weak hands, don't be weak minded, have Faith in this amazing company and HOLD Long & Strong! Buy more when you can, and buy often. I'm so glad i kept adding yesterday.
Soon we will be looking back wishing we could be buying @ these levels!
GLTA!! Lets GOO!!
I did say a Reverse-ForwardSplit
What is a 'Reverse/Forward Stock Split'
A reverse/forward stock split is a stock split strategy used by companies to eliminate shareholders that hold fewer than a certain number of shares of that company's stock. A reverse/forward stock split uses a reverse stock split followed by a forward stock split. The reverse split reduces the overall number of shares a shareholder owns, causing some shareholders who hold less than the minimum required by the split to be cashed out. The forward stock split increases the overall number of shares a shareholder owns. A reverse/forward stock split is usually used by companies to cash out shareholders with a less-than-certain amount of shares. This is believed to cut administrative costs by reducing the number of shareholders who require mailed proxies and other documents.
BREAKING DOWN 'Reverse/Forward Stock Split'
For example, if a company declares a reverse/forward stock split, it could start by exchanging one share for 100 shares that the investor holds. Investors with fewer than 100 shares would not be able to do the split and would, therefore, be cashed out. The company would then do a forward stock split for 100 for 1, which will bring shareholders that were not cashed out to their original number of shares. This would reduce the overall number of shareholders, as shareholders who started the process with less than 100 shares and were cashed out would no longer be shareholders at the end of the process. They do not get shares back during the forward split since they have already been cashed out.
You are right it most likely would hurt smaller investors, but an incentive them to buy more shares
TD showing.2070 for a day range high...40 minutes from lunch in NY.
Should settle some...But isn't this fun
Got this sensation again from looking at the trading action that institutional investors buy...did not expect it yet, but it sure looks that way
they are very accurate with their update, but I agree that more is in the pipeline
There were some massive buys in the past few minutes!!!
Definitely not IHUB investors...wonder who?
Passed $.20!!!!!!!!!!!!!! WHOOO HOOO!!!!
Ok I might be wrong on .20! Let’s move the goal to .21 today!
RXMD RXMD RXMD RXMD RXMD RXMD RXMD RXMD RXMD RXMD
clipped .20 on TD going into lunch..
wow wow wow - I will like seeing more of that.
Why? At .20 it would take a 1 for 20 just to reach the $4.00 needed and would damage a lot of smaller investors. Many companies on the NASD have more than 300m O/S and trade multiple dollars. They would also need some wiggle room. A better scenario for that would be a smaller split at a much higher price so "imminent" is a little premature. JMO.
Oh ! you are ? then in this case, do you think that if they change their mind not to sell for us, should they be liable ? and we should consider after LOI usually end up as a done deal ??
Nice test of support at .19 and if it holds .20 will come after lunch!
It took 3 years but worth the wait if you bought under .02
NEW TWEET from $RXMD, its what we already know but still awesome
Progressive Care
@ProgressCareUS
SeeThruEquity Upgrades RXMD Price Target to $0.35 per Share @ProgressiveCareUS @pharmcorx
#stock #news #otc #updates http://progressivecareus.com/seethruequity-upgrades-rxmd-price-target-to-0-35-per-share/ …
https://twitter.com/ProgressCareUS
Well said ! And Folks ! never underestimate a fast growing company like RXMD's power of upward mobility !!! Weeeeeee........
A Reverse-Forward-Split is almost imminent,IMO,due to share structure,a sure path to NASDAQ,GO RXMD
RXMD
RXMD IS A BEAST!!!
.35 coming next week! she's a beauty!! i'm glad the mindless sheep are all gone!!!
yup, busting through 20 any minute now!
Insanity. People are paying .002 over ask to get large quantities. Two words for this stock. "Absolute Beast"
We are getting close to $.20 again!
TheSerb,
wow 10 cent goal now 35 cents!
volume is robust, progressive remains a beast!
I think we could uplist again at this rate, perhaps late 18?
What a run! and this company will stabilize at much higher
prices. company well run and is transparent.
snupDAWGoled
perspective- this company is still cheap on a forward investment valuation.
there are many companies with no revenue, less future potential, and lots of debt trading with higher market cap than RXMD.
Yup, MM know $0.35 near term has become must even without up grade released, so intentionally made it lower pps to collect more cheap shares is possible. And those not buy back soon enough would forever left behind . Weeeeeee !!!!
I committed my shares to sell at $1.25
Can they sell into a State mail order/internet if they are licensed in that State?
I don't count out of state licenses until a LOI is present. I'm working with today only. I will raise my valuation as they are licensed not before. Till then I see .40 to .60 with what we have now which is a pretty fair estimate and I'm sure you'd all be happy to see it until new info is released.
Folks , past experience tell us that SeeThruEquity Upgrades RXMD target is correct and reliable. So all you have to do just be patient. Firmly believe what you are holding is the key to make big BUCKs like Werrent Buffer ! Long and Strong !!!!!
I’m new here but I have to ask, has VERT played these games all the up the ladder?
Grabbed the dip yesterday
Good post, but like Jimmy said, take into account the out of state lic. which are heating up. And the new applications for more out of state lic.
Location, does mean a lot look at WAL****** they are on every corner so to speak,GO RXMD
RXMD
XJ- indeed! I had this odd dream....
there was a selloff dip or something and everyone was going all mad-bull in the forum. really weird. anyway... :D
We just need to break that resistance at .19 and hold it first
4 mil traded in the first half hour! Let’s crack and hold .20.
trade sideways for a few days and reset
$.20 by lunch....close around $.22 would be awesome!
Do NOT sell for weekend beer money!
RXMD!
When RXMD shows earnings they will get a minimum P/E of 30 probably higher!
Stock is still cheap and growth should come at the rate of 3 new locations
this year and probably 6 the following year and doubling every year after
that. This is a growth company in the making. You have to be doing something right to have the revenues they have had so far. They will in
my opinion be smart and pick locations that will be a boom for the business, paying more money for the right location is a solid investment.
If it works great in Miami, it will work great any where in the U.S. and
the better the location the higher the revenues, but proven has already
been achieved so now its a matter of expansion.
JMO
Mickey
Followers
|
745
|
Posters
|
|
Posts (Today)
|
7
|
Posts (Total)
|
194604
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |